Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)

NCT03669523 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Bone Metastases

Interventions

DRUG: Denosumab-nivolumab combination

Sponsor

Centre Hospitalier Annecy Genevois

Collaborators

[object Object]